These anti-inflammatory actions are implicated in the protective roles observed for TGR5 activation or SBA modulation in models of colitis (97, 99), rheumatoid arthritis (79), and diabetic retinopathy (100). This evidence concerns the gene GPBAR1 and rheumatoid arthritis.